Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Epilepsy

Free Subscription Articles published in Lancet Retrieve available abstracts of 12 articles: HTML format Text format

Single Articles

June 2019
1. THE LANCET
   Epilepsy prevention: an urgent global unmet need.
   Lancet. 2019;393:2564.
   PubMed     Text format    
   
   
   April 2019
2. SILBERGLEIT R, Elm JJ
   Levetiracetam no better than phenytoin in children with convulsive status epilepticus.
   Lancet. 2019 Apr 17. pii: S0140-6736(19)30896.
   PubMed     Text format    
   
   
   
3. DALZIEL SR, Borland ML, Furyk J, Bonisch M, et al
   Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
   Lancet. 2019 Apr 17. pii: S0140-6736(19)30722.
   PubMed     Text format     Abstract available
   
   
   
4. LYTTLE MD, Rainford NEA, Gamble C, Messahel S, et al
   Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.
   Lancet. 2019 Apr 17. pii: S0140-6736(19)30724.
   PubMed     Text format     Abstract available
   
   
   February 2019
5. THE LANCET
   From wonder and fear: make epilepsy a global health priority.
   Lancet. 2019;393:612.
   PubMed     Text format    
   
   
   January 2019
6. THIJS RD, Surges R, O'Brien TJ, Sander JW, et al
   Epilepsy in adults.
   Lancet. 2019 Jan 24. pii: S0140-6736(18)32596.
   PubMed     Text format     Abstract available
   
   
   August 2018
7. SEN A, Nashef L
   New regulations to cut valproate-exposed pregnancies.
   Lancet. 2018;392:458-460.
   PubMed     Text format    
   
   
   July 2018
8. THE LANCET
   Cannabinoids: just like any other medication?
   Lancet. 2018;392:188.
   PubMed     Text format    
   
   
   March 2018
9. VARADKAR S
   Cannabidiol for drop seizures in Lennox-Gastaut syndrome.
   Lancet. 2018;391:1006-1007.
   PubMed     Text format    
   
   
   
10. THIELE EA, Marsh ED, French JA, Mazurkiewicz-Beldzinska M, et al
    Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
    Lancet. 2018;391:1085-1096.
    PubMed     Text format     Abstract available
    
    
    October 2016
11. BAYER R, Johns DM, Galea S
    A false aura of scientific controversy around salt?
    Lancet. 2016;388:2109.
    PubMed     Text format    
    
    
    
12. FRENCH JA, Lawson JA, Yapici Z, Ikeda H, et al
    Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.
    Lancet. 2016;388:2153-2163.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Epilepsy is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: